Grindrod Shipping Holdings Ltd. Announces Fleet Update – Re-delivery of Doric Breeze
SINGAPORE, July 13, 2020 (GLOBE NEWSWIRE) — Grindrod Shipping Holdings Ltd. (NASDAQ: GRIN) (JSE: GSH) (“Grindrod Shipping” or “Company” or […]
The Chefs’ Warehouse to Announce Second Quarter 2020 Results on July 29, 2020
RIDGEFIELD, Conn., July 13, 2020 (GLOBE NEWSWIRE) — The Chefs’ Warehouse, Inc. (NASDAQ: CHEF) today announced that the Company intends […]
Synaptics to Report Fourth Quarter Fiscal 2020 Results on August 5, 2020
SAN JOSE, Calif., July 13, 2020 (GLOBE NEWSWIRE) — Synaptics® Incorporated (NASDAQ: SYNA), today announced that it will report financial […]
TFI International tiendra une conférence téléphonique pour discuter des résultats du deuxième trimestre de 2020
MONTRÉAL, 13 juill. 2020 (GLOBE NEWSWIRE) — TFI International Inc. (NYSE et TSX: TFII), un chef de file nord-américain du […]
TFI International to Host Conference Call to Discuss Second Quarter 2020 Results
MONTREAL, July 13, 2020 (GLOBE NEWSWIRE) — TFI International Inc. (NYSE and TSX: TFII), a North American leader in the […]
Seacoast Banking Corporation of Florida Announces New Hire, Austen Carroll, to Lead Commercial Banking; Julie Kleffel Promoted to Chief Banking Officer
STUART, Fla., July 13, 2020 (GLOBE NEWSWIRE) — Seacoast Banking Corporation of Florida (NASDAQ: SBCF) (the “Company” or “Seacoast”) today […]
Sensus Healthcare to Present at COVID-19 Webinar Hosted by Maxim Group on July 16th
BOCA RATON, Fla., July 13, 2020 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in […]
Altimmune Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
GAITHERSBURG, Md., July 13, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it […]
Otonomy Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
SAN DIEGO, July 13, 2020 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative […]
Merus and Caris Life Sciences Announce Collaboration to Detect NRG1 Fusions in Cancer Patients
Caris to provide DNA and RNA molecular testing to support patient identification and enrollment for Merus’ Zenocutuzumab Phase 1/2 eNRGy trialUTRECHT, […]
